CLAIM CARD
The direct receipts support a narrow working claim: Supplementation was associated with reduced risk of MI (relative risk [RR], 0.87; 95% CI, 0.80 to 0.96), high certainty NNT of 272; but not CVD events (RR, 0.95; 95% CI, 0.90 to 1.00). The context receipts provide source breadth and boundary checks, not independent confirmation of the lead claim.
Evidence grade: exploratory
Contradiction status: none
Publication: 556ed33d-b232-4c19-a24c-849a8c2d81a6
Provenance: Derivation Web chain
Citation Support
source_1Effect of Omega-3 Dosage on Cardiovascular Outcomessource_2Effects of Omega-3 Polyunsaturated Fatty Acids on Brain Functions: A Systematic Reviewsource_3Higher ratio of plasma omega-6/omega-3 fatty acids is associated with greater risk of all-cause, cancer, and cardiovascular mortality: A population-based cohort study in UK Biobanksource_4Omega-3 fatty acids for the primary and secondary prevention of cardiovascular diseasesource_5The Effects of Vitamin D Supplementation on Musculoskeletal Health: The VITAL and DO-Health Trials